ZA9711579B - Microparticulate form of a tetrahydropyridine derivative. - Google Patents

Microparticulate form of a tetrahydropyridine derivative.

Info

Publication number
ZA9711579B
ZA9711579B ZA9711579A ZA9711579A ZA9711579B ZA 9711579 B ZA9711579 B ZA 9711579B ZA 9711579 A ZA9711579 A ZA 9711579A ZA 9711579 A ZA9711579 A ZA 9711579A ZA 9711579 B ZA9711579 B ZA 9711579B
Authority
ZA
South Africa
Prior art keywords
microparticulate form
tetrahydropyridine derivative
tetrahydropyridine
derivative
microparticulate
Prior art date
Application number
ZA9711579A
Other languages
English (en)
Inventor
Jean-Pierre Chambon
Olivier Monnier
Antoine Caron
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of ZA9711579B publication Critical patent/ZA9711579B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
ZA9711579A 1996-12-23 1997-12-23 Microparticulate form of a tetrahydropyridine derivative. ZA9711579B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9615905A FR2757510B1 (fr) 1996-12-23 1996-12-23 Forme microparticulaire d'un derive de tetrahydropyridine

Publications (1)

Publication Number Publication Date
ZA9711579B true ZA9711579B (en) 1998-06-25

Family

ID=9499044

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9711579A ZA9711579B (en) 1996-12-23 1997-12-23 Microparticulate form of a tetrahydropyridine derivative.

Country Status (38)

Country Link
US (4) US20020028247A1 (uk)
EP (1) EP0950051B1 (uk)
JP (2) JP4422214B2 (uk)
KR (1) KR100455797B1 (uk)
CN (1) CN1088698C (uk)
AR (1) AR009673A1 (uk)
AT (1) ATE250032T1 (uk)
AU (1) AU730302B2 (uk)
BR (1) BR9714177A (uk)
CA (1) CA2275593C (uk)
CO (1) CO4920213A1 (uk)
CZ (1) CZ294272B6 (uk)
DE (1) DE69724999T2 (uk)
DK (1) DK0950051T3 (uk)
DZ (1) DZ2386A1 (uk)
EE (1) EE04112B1 (uk)
EG (1) EG24749A (uk)
ES (1) ES2207758T3 (uk)
FR (1) FR2757510B1 (uk)
HK (1) HK1024000A1 (uk)
HU (1) HU224348B1 (uk)
IL (1) IL129937A (uk)
IN (1) IN186977B (uk)
IS (1) IS2064B (uk)
MY (1) MY126298A (uk)
NO (1) NO311569B1 (uk)
NZ (1) NZ336129A (uk)
PL (1) PL190098B1 (uk)
PT (1) PT950051E (uk)
RU (1) RU2193031C2 (uk)
SI (1) SI0950051T1 (uk)
SK (1) SK283917B6 (uk)
TR (1) TR199901362T2 (uk)
TW (1) TW534820B (uk)
UA (1) UA66776C2 (uk)
WO (1) WO1998028272A1 (uk)
YU (1) YU49427B (uk)
ZA (1) ZA9711579B (uk)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100579514C (zh) * 2001-07-06 2010-01-13 生命周期药物公司 通过受控制的凝聚而制备颗粒物的方法以及提高生物利用度的方法
BE1015641A4 (fr) * 2003-05-26 2005-07-05 Mariani Jean Paul Micronisation 70.
RU2472490C1 (ru) * 2011-08-05 2013-01-20 Открытое акционерное общество "Биосинтез" Средство для лечения кожных гнойных инфекций, составы и способы получения

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US562883A (en) * 1896-06-30 Thill-coupling
FR2531707A1 (fr) * 1982-08-16 1984-02-17 Midy Spa Trifluoromethylphenyltetrahydropyridines substituees a activite anorexigene, un procede de preparation et compositions pharmaceutiques
US4826689A (en) * 1984-05-21 1989-05-02 University Of Rochester Method for making uniformly sized particles from water-insoluble organic compounds
FR2627696B1 (fr) * 1988-02-26 1991-09-13 Fournier Innovation Synergie Nouvelle forme galenique du fenofibrate
FR2639226B1 (fr) * 1988-11-18 1993-11-05 Sanofi Utilisation de trifluoromethylphenyltetrahydropyridines pour la preparation de medicaments destines a combattre les troubles anxio-depressifs
FR2662355B1 (fr) * 1990-05-22 1994-11-10 Sanofi Sa Utilisation de la 1-[2-(2-naphtyl)ethyl]-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de troubles cerebraux et neuronaux.
WO1994009898A1 (de) * 1992-10-26 1994-05-11 Schwarz Pharma Ag Verfahren zur herstellung von mikrokapseln
US5560932A (en) * 1995-01-10 1996-10-01 Nano Systems L.L.C. Microprecipitation of nanoparticulate pharmaceutical agents
US5662883A (en) * 1995-01-10 1997-09-02 Nanosystems L.L.C. Microprecipitation of micro-nanoparticulate pharmaceutical agents
US6489334B2 (en) * 1996-12-23 2002-12-03 Sanofi-Synthelabo Method for the crystallization of a tetrahydropyridin derivative and resulting crystalline forms
FR2763847B1 (fr) * 1997-05-28 2003-06-06 Sanofi Sa Utilisation de tetrahydropyridines 4-substituees pour fabriquer des medicaments agissant sur le tgf-beta-1
US20020147216A1 (en) * 2000-01-31 2002-10-10 Yuhong Zhou Mucin synthesis inhibitors

Also Published As

Publication number Publication date
US20020192292A1 (en) 2002-12-19
CZ229199A3 (cs) 1999-09-15
EE04112B1 (et) 2003-08-15
TR199901362T2 (xx) 1999-09-21
RU2193031C2 (ru) 2002-11-20
ATE250032T1 (de) 2003-10-15
DE69724999D1 (de) 2003-10-23
CN1241179A (zh) 2000-01-12
DE69724999T2 (de) 2004-07-22
JP2009280581A (ja) 2009-12-03
IN186977B (uk) 2001-12-22
SK82999A3 (en) 1999-12-10
IS2064B (is) 2005-11-15
DZ2386A1 (fr) 2002-12-28
FR2757510B1 (fr) 2000-01-07
IL129937A0 (en) 2000-02-29
NO993077L (no) 1999-06-22
CZ294272B6 (cs) 2004-11-10
CN1088698C (zh) 2002-08-07
IL129937A (en) 2002-09-12
JP2001507013A (ja) 2001-05-29
EP0950051B1 (fr) 2003-09-17
AU5668598A (en) 1998-07-17
IS5077A (is) 1999-06-10
AU730302B2 (en) 2001-03-01
US20020028247A1 (en) 2002-03-07
US20100021541A1 (en) 2010-01-28
SI0950051T1 (en) 2004-02-29
NO311569B1 (no) 2001-12-10
HUP0001181A2 (hu) 2000-11-28
KR100455797B1 (ko) 2004-11-06
HUP0001181A3 (en) 2003-03-28
NZ336129A (en) 2000-11-24
EE9900263A (et) 2000-02-15
MY126298A (en) 2006-09-29
CO4920213A1 (es) 2000-05-29
YU28899A (sh) 2000-03-21
CA2275593A1 (en) 1998-07-02
ES2207758T3 (es) 2004-06-01
FR2757510A1 (fr) 1998-06-26
NO993077D0 (no) 1999-06-22
JP4422214B2 (ja) 2010-02-24
KR20000069503A (ko) 2000-11-25
AR009673A1 (es) 2000-04-26
HU224348B1 (hu) 2005-08-29
US20080255365A1 (en) 2008-10-16
BR9714177A (pt) 2000-02-29
EP0950051A1 (fr) 1999-10-20
PT950051E (pt) 2004-02-27
CA2275593C (en) 2005-12-20
YU49427B (sh) 2006-01-16
HK1024000A1 (en) 2000-09-29
PL334276A1 (en) 2000-02-14
TW534820B (en) 2003-06-01
DK0950051T3 (da) 2004-01-26
WO1998028272A1 (fr) 1998-07-02
SK283917B6 (sk) 2004-05-04
UA66776C2 (uk) 2004-06-15
PL190098B1 (pl) 2005-10-31
EG24749A (en) 2010-07-20

Similar Documents

Publication Publication Date Title
ZA962200B (en) Piperidine derivatives
IL127566A0 (en) Substituted 6,5-hetero- bicyclic derivatives
HK1019597A1 (en) Substituted 6, 6-hetero-bicyclic derivatives
ZA976224B (en) 4-hydroxy-piperidine derivatives.
ZA9811345B (en) Piperidine derivatives
ZA952431B (en) New piperidine derivatives
AU5412798A (en) Boiler
ZA979725B (en) Benzoaxozole derivative.
ZA9710653B (en) 4-hydroxy-piperidine derivatives.
ZA9711579B (en) Microparticulate form of a tetrahydropyridine derivative.
ZA979781B (en) Piperidine derivatives.
ZA972329B (en) Piperidine derivatives
ZA97329B (en) Piperidine or tetrahydropyridine derivatives
HU9700609D0 (en) 1,25-dihydroxy-12,22,23-trisdehydro-cholecalciferol derivatives
GB2312698B (en) Packer
ZA971357B (en) 1,4-dihydropyridine compounds
ZA973394B (en) Plaster containing 1,2-ethanediol derivative or a salt thereof.
IL135195A0 (en) Substituted piperidine derivatives
EP0727610A3 (de) Heizkessel
PL57055Y1 (en) Boiler
HU9702315D0 (en) 4-hydroxy-piperidine derivatives
PL105757U1 (en) Straw-fired boiler
ZA975336B (en) A cupboard.
IL132162A (en) 2,3-epoxypropionamide derivatives
IL132162A0 (en) 2, 3-Epoxypropionamide derivatives